Results 311 to 320 of about 31,885,483 (388)

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Contrasting effects of mismatch locations on Z-DNA formation under bending force. [PDF]

Chem Sci
Park S, Yi J, Lee NK.
europepmc   +1 more source

Intrageneric Structure of Streptococcus Based on Comparative Analysis of Small-Subunit rRNA Sequences

, 1991
Robert W Bentley, James A. Leigh, M. D. COLLINS   +2 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Enhanced genome editing with a Streptococcus equinus Cas9. [PDF]

Commun Biol
Liu J, Wang Y, Wei J, Wang S, Li M, Huang Z, Zhang S, Liu H, Huang J, Wang Y.   +9 more
europepmc   +1 more source

Region-based tracking in an image sequence

, 1992
François G. Meyer, Patrick Bouthémy
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Flipons enable genomes to learn by intermediating the exchange of energy for information. [PDF]

J R Soc Interface
Herbert A.
europepmc   +1 more source

Linking yeast genetics to mammalian genomes: identification and mapping of the human homolog of CDC27 via the expressed sequence tag (EST) data base.

, 1993
Stuart Tugendreich, Mark S. Boguski, MF Seldin, Philip Hieter   +3 more
openalex   +1 more source

Overview and Prospects of DNA Sequence Visualization. [PDF]

Int J Mol Sci
Wu Y, Xie X, Zhu J, Guan L, Li M.
europepmc   +1 more source